FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283461331> ?p ?o ?g. }

• W4283461331 endingPage "1853" @default.
• W4283461331 startingPage "1847" @default.
• W4283461331 abstract "In clinical practice, constipation is one of the most frequent adverse events caused by drugs for overactive bladder (OAB). The occurrence of constipation greatly deteriorates the patient's quality of life. The aim of the study was to evaluate and compare the effects of three commonly used β3 agonists and anticholinergic drugs on the defecation status in patients with OAB.We retrospectively reviewed the defecation status in patients who received mirabegron, solifenacin, or fesoterodine for OAB. We evaluated changes in the (a) urological parameters using the OAB symptom score (OABSS) and (b) defecation status using the Bristol Stool Form Scale (BSFS) and constipation scoring system (CSS) following 12 weeks of drug administration.We analyzed data from 165 patients (mirabegron=56, fesoterodine=52, and solifenacin=57). The solifenacin group showed a significant decrease in BSFS (from 3.2±1.0 at baseline to 2.3±12 post-treatment) and an increase in hardened stools (p<0.001). Elimination worsened as assessed by almost all items, and the total modified CSS scores worsened significantly from 4.8±2.6 points at baseline to 8.O±4.8 points after 12 weeks of solifenacin treatment (p<0.001). The mirabegron group showed no changes in any of the CSS items. In the fesoterodine group, the CSS scores for completeness and assistance increased significantly after treatment (p<0.001 and p=0.013, respectively).All three drugs were effective for OAB. Mirabegron had almost no effect on constipation; fesoterodine, an anticholinergic drug, also had hardly any effect on defecation." @default.
• W4283461331 created "2022-06-26" @default.
• W4283461331 creator A5027874681 @default.
• W4283461331 creator A5033916365 @default.
• W4283461331 creator A5041999667 @default.
• W4283461331 creator A5048826083 @default.
• W4283461331 creator A5050794980 @default.
• W4283461331 creator A5064560515 @default.
• W4283461331 creator A5084815637 @default.
• W4283461331 date "2022-01-01" @default.
• W4283461331 modified "2023-09-26" @default.
• W4283461331 title "Effects of β3 Agonists and Anticholinergic Drugs on Defecation in Patients With Overactive Bladder" @default.
• W4283461331 cites W1501189048 @default.
• W4283461331 cites W1965106381 @default.
• W4283461331 cites W1967312126 @default.
• W4283461331 cites W1986758727 @default.
• W4283461331 cites W2002743872 @default.
• W4283461331 cites W2027752587 @default.
• W4283461331 cites W2033208945 @default.
• W4283461331 cites W2046549547 @default.
• W4283461331 cites W2073754334 @default.
• W4283461331 cites W2078614939 @default.
• W4283461331 cites W2094737423 @default.
• W4283461331 cites W2109238714 @default.
• W4283461331 cites W2116172247 @default.
• W4283461331 cites W2125211467 @default.
• W4283461331 cites W2131173377 @default.
• W4283461331 cites W2169333949 @default.
• W4283461331 cites W2286258673 @default.
• W4283461331 cites W2525374547 @default.
• W4283461331 cites W2587662747 @default.
• W4283461331 cites W2606250578 @default.
• W4283461331 cites W2608412644 @default.
• W4283461331 cites W2741979100 @default.
• W4283461331 cites W2770867475 @default.
• W4283461331 cites W2800933213 @default.
• W4283461331 cites W2916765119 @default.
• W4283461331 cites W2945310457 @default.
• W4283461331 cites W2980710301 @default.
• W4283461331 cites W3026007643 @default.
• W4283461331 doi "https://doi.org/10.21873/invivo.12902" @default.
• W4283461331 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35738641" @default.
• W4283461331 hasPublicationYear "2022" @default.
• W4283461331 type Work @default.
• W4283461331 citedByCount "0" @default.
• W4283461331 crossrefType "journal-article" @default.
• W4283461331 hasAuthorship W4283461331A5027874681 @default.
• W4283461331 hasAuthorship W4283461331A5033916365 @default.
• W4283461331 hasAuthorship W4283461331A5041999667 @default.
• W4283461331 hasAuthorship W4283461331A5048826083 @default.
• W4283461331 hasAuthorship W4283461331A5050794980 @default.
• W4283461331 hasAuthorship W4283461331A5064560515 @default.
• W4283461331 hasAuthorship W4283461331A5084815637 @default.
• W4283461331 hasBestOaLocation W42834613311 @default.
• W4283461331 hasConcept C108797546 @default.
• W4283461331 hasConcept C126322002 @default.
• W4283461331 hasConcept C126894567 @default.
• W4283461331 hasConcept C142724271 @default.
• W4283461331 hasConcept C197934379 @default.
• W4283461331 hasConcept C204787440 @default.
• W4283461331 hasConcept C2777912814 @default.
• W4283461331 hasConcept C2778164427 @default.
• W4283461331 hasConcept C2778689640 @default.
• W4283461331 hasConcept C2778941218 @default.
• W4283461331 hasConcept C2779502394 @default.
• W4283461331 hasConcept C2781112942 @default.
• W4283461331 hasConcept C71924100 @default.
• W4283461331 hasConceptScore W4283461331C108797546 @default.
• W4283461331 hasConceptScore W4283461331C126322002 @default.
• W4283461331 hasConceptScore W4283461331C126894567 @default.
• W4283461331 hasConceptScore W4283461331C142724271 @default.
• W4283461331 hasConceptScore W4283461331C197934379 @default.
• W4283461331 hasConceptScore W4283461331C204787440 @default.
• W4283461331 hasConceptScore W4283461331C2777912814 @default.
• W4283461331 hasConceptScore W4283461331C2778164427 @default.
• W4283461331 hasConceptScore W4283461331C2778689640 @default.
• W4283461331 hasConceptScore W4283461331C2778941218 @default.
• W4283461331 hasConceptScore W4283461331C2779502394 @default.
• W4283461331 hasConceptScore W4283461331C2781112942 @default.
• W4283461331 hasConceptScore W4283461331C71924100 @default.
• W4283461331 hasIssue "4" @default.
• W4283461331 hasLocation W42834613311 @default.
• W4283461331 hasLocation W42834613312 @default.
• W4283461331 hasLocation W42834613313 @default.
• W4283461331 hasOpenAccess W4283461331 @default.
• W4283461331 hasPrimaryLocation W42834613311 @default.
• W4283461331 hasRelatedWork W1517488317 @default.
• W4283461331 hasRelatedWork W2494945167 @default.
• W4283461331 hasRelatedWork W2509856222 @default.
• W4283461331 hasRelatedWork W2736206711 @default.
• W4283461331 hasRelatedWork W2766091099 @default.
• W4283461331 hasRelatedWork W3018245904 @default.
• W4283461331 hasRelatedWork W3152583854 @default.
• W4283461331 hasRelatedWork W3212015874 @default.
• W4283461331 hasRelatedWork W4283461331 @default.
• W4283461331 hasRelatedWork W2727572333 @default.
• W4283461331 hasVolume "36" @default.
• W4283461331 isParatext "false" @default.

• next